Drug Design Reviews - Online

Anti Tumor Necrosis Factor-a Monoclonal Antibody (Infliximab) Therapy in Patients with Inflammatory Bowel Disease (IBD): Applications and Side Effects
pp. 111-117(7)
Authors: Amati L.; Passeri M.E.; Mastronardi M.L.; Jirillo E.

Vascular Targeting: A New Antitumor Activity
pp. 119-122(4)
Authors: Ribatti D.; Crivellato E.; Russo F.; Cirulli T.; Vacca A.

Cell Division Cycle 25 (Cdc25) Phosphatase Inhibitors as Antitumor Agents
pp. 123-132(10)
Authors: Ham S.W.; Carr B.I.

Unique Profile of Lafutidine, A Novel Histamine H2-Receptor Antagonist - Mucosal Protection Throughout Gastrointestinal Tract Mediated by Capsaicin-Sensitive Afferent Neurons -
pp. 133-144(12)
Authors: Onodera S.; Nishida K.; Takeuchi K.

Altered Peptide Ligand Antagonism: From Immune Evasion to Immunotherapy
pp. 145-151(7)
Authors: Minigo G.; Plebanski M.; Apostolopoulos V.

Contribution to Immunochemical Analysis of Polysaccharides in Medicinal Plants
pp. 153-159(7)
Authors: Dogasaki C.; Kakuno Y.; Honda M.; Takada N.; Maruyama T.; Nishijima M.; Adachi Y.; Ohno N.; Yadomae T.; Miyazaki T.

Cellular Uptake of Cell-Penetrating Peptides
pp. 161-173(13)
Authors: Eiríksdottir E.; Myrberg H.; Hansen M.; Langel U.

Isolated-Perfused Heart: The Preparation that has been used as a Research Tool for More than a Century
pp. 175-184(10)
Author: Igic R.